Study blasts agenciesfor radiation standards
A study from the Institute for Energy and Environment Research blasted U.S. regulators for relying on radiation protection rules that underestimate exposure risks for women and children because they are based on standards of a “reference man,” a hypothetical 20 to 30-year-old white male.
A study from the Institute for Energy and Environment Research blasted U.S. regulators for relying on radiation protection rules that underestimate exposure risks for women and children because they are based on standards of a “reference man,” a hypothetical 20 to 30-year-old white male.
At least three federal agencies-the Environmental Protection Agency, Nuclear Regulatory Commission, and Department of Energy-still use reference-man criteria to guide radiation dose regulations and compliance assessment. According to IEER president Arjun Makihjani, Ph.D., current policy fails to protect groups other than young adult males. A female infant, for instance, has about a seven times greater chance of developing cancer than a 30-year-old man from the same radiation dose. The report recommends that compliance with radiation protection always be estimated by calculating doses for those at the greatest risk from excess exposure.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
